2.7% continued all medications, but switched at least one, of which 2.9% were in the intervention population and 2.6% in the control population.
2,7% héldu áfram öllum lyfjum, en skiptu að minnsta kosti einu, þar af 2,9% í tilfellahópi og 2,6% í viðmiðunarhópi.